PartnershipUpdated on 23 April 2026
R&D collaboration for pre-clinical assets
About
CureRoot is actively seeking strategic R&D collaborations with global pharmaceutical companies to co-develop our high-potency pre-clinical assets. We offer our partners exclusive access to completely novel chemical matter derived from proprietary African plant scaffolds.
Through co-development, we aim to combine our discovery and early-validation capabilities with our partners' clinical development and regulatory expertise, accelerating our oncology and infectious disease candidates through IND-enabling studies and into human trials.
Organisation
Similar opportunities
Expertise
Humanized multi-organoid models for translational drug discovery
Agne Vaitkeviciene
Business Development Director at abc biopply
Solothurn, Switzerland
Partnership
Do Youn Chun
Chief Technical Officer at AT-31 BIO Inc.
Daegu, South Korea